Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8600
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorJanicijevic A.-
dc.contributor.authorDejanovic S.-
dc.contributor.authorBorovcanin, Milica-
dc.date.accessioned2020-09-19T16:11:39Z-
dc.date.available2020-09-19T16:11:39Z-
dc.date.issued2018-
dc.identifier.issn1820-8665-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8600-
dc.description.abstract© 2017 Slavica Minic Janicijevic et al., published by De Gruyter Open 2017. Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family and plays an important role in neuroplasticity, differentiation and survival of neurons, as well as their function. Neuroinflammation has been explored in the pathophysiology of many mental disorders, such as schizophrenia. Cytokines representing different types of immune responses have an impact on neurogenesis and BDNF expression. Cross-regulation of BDNF and cytokines is accomplished through several signalling pathways. Also, typical and atypical antipsychotic drugs variously modulate the expression of BDNF and serum levels of cytokines, which can possibly be used in evaluation of therapy effectiveness. Comorbidity of metabolic syndrome and atopic diseases has been considered in the context of BDNF and cytokines interplay in schizophrenia.-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceSerbian Journal of Experimental and Clinical Research-
dc.titleInterplay of Brain-Derived Neurotrophic Factor and Cytokines in Schizophrenia-
dc.identifier.doi10.1515/sjecr-2017-0031-
dc.identifier.scopus2-s2.0-85042060901-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

141

Downloads(s)

159

Files in This Item:
File Description SizeFormat 
10.1515-sjecr-2017-0031.pdf840.2 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons